Aromatase inhibitors for subfertile women with polycystic ovary syndrome Summary of a Cochrane review

Letrozole appears to be superior to clomiphene citrate for ovulation induction in subfertile women with polycystic ovary syndrome.

Like Comment

Authors

Sebastian Franik, B.Sc., Jan A.M. Kremer, Ph.D., Willianne L.D.M. Nelen, Ph.D., Cynthia Farquhar, M.P.H., Jane Marjoribanks, M.P.H.

Volume 103, Issue 2, Pages 353-355

Abstract

Polycystic ovary syndrome (PCOS) is a common cause of anovulatory subfertility. We evaluated the effectiveness and safety of aromatase inhibitors compared with other methods of ovulation induction in women with anovulatory PCOS.

Read the full text at: http://www.fertstert.org/article/S0015-0282(14)02267-5/fulltext


Fertility and Sterility

Editorial Office, American Society for Reproductive Medicine

Fertility and Sterility® is an international journal for obstetricians, gynecologists, reproductive endocrinologists, urologists, basic scientists and others who treat and investigate problems of infertility and human reproductive disorders. The journal publishes juried original scientific articles in clinical and laboratory research relevant to reproductive endocrinology, urology, andrology, physiology, immunology, genetics, contraception, and menopause. Fertility and Sterility® encourages and supports meaningful basic and clinical research, and facilitates and promotes excellence in professional education, in the field of reproductive medicine.

No comments yet.